UNSPSC 51172334: Trientine hydrochloride

This classification denotes a metal chelator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HC3NX54582. European Medicines Agency schedules Trientine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04953MIG. Trientine hydrochloride generally arises in the molecular formula C6H18N4.2CLH. The term 'trientine hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule trientine hydrochloride under HS 29212900.

As of Q4 2014, TRIENTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Trientine hydrochloride bears US NLM identifiers UMLS ID C0770325 and NCI Concept Code C61987. SMILES: C(CNCCNCCN)N.CL.CL.

UNSPSC 51172334 Trientine hydrochloride is a Commodity code that state and local procurement systems tag to drug testing and specimen collection services rather than pharmaceutical inventory. Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services illustrates the actual scope: the county is soliciting staffing for two collection sites (Plano and McKinney), operation of randomized testing notification systems, laboratory screening and confirmation testing (immunoassay with LC/MS/MS or GC/MS confirmation), and alternative testing methodologies including oral fluid and hair analysis. Annual testing demand totals approximately 25,031 tests across five-panel and six-panel screens. The contract reflects correctional and community supervision applications—state and local corrections departments, probation and parole agencies, and specialty criminal justice divisions dominate issuance under this code's tag.

Collin County, Texas represents the identified recent activity. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026, with proposals due July 23, 2026 at 2:00 p.m., seeking a vendor to manage specimen collection and drug testing under a two-year initial term commencing September 1, 2026, plus three optional one-year renewals not to exceed five years total. The estimated contract value is $600,000. Pricing is per-test across three service models (screening only, screening with confirmation, or screening with automatic positive confirmation), and vendors must hold SAMHSA, Texas DPS, or CAP lab certification. Evaluation criteria weight vendor understanding and firm qualifications at 30 and 25 points respectively, client references at 15 points, and cost at 30 points, with optional Phase 2 demonstrations and interviews worth up to 30 additional points. Award selection favors the responsible contractor whose proposal represents the best evaluated offer considering both price and qualifications.